Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 16, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Methotrexate Injection USP".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 16, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Methotrexate Injection USP".